Relapsed Rhabdomyosarcoma

Relapsed rhabdomyosarcoma (RMS) represents a significant therapeutic challenge. Nearly one-third of patients diagnosed with localized RMS and over two-thirds of patients with metastatic RMS will experience disease recurrence following primary treatment, generally within three years. Clinical feature...

Descripción completa

Detalles Bibliográficos
Autores principales: Heske, Christine M., Mascarenhas, Leo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922213/
https://www.ncbi.nlm.nih.gov/pubmed/33671214
http://dx.doi.org/10.3390/jcm10040804

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922213/
https://www.ncbi.nlm.nih.gov/pubmed/33671214
http://dx.doi.org/10.3390/jcm10040804

Ejemplares similares